DK1644045T3 - Ekstracellulære vesikler fra ikke-patogene amöber, der er anvendelige som vehikel til overförsel af et molekyle af interesse til en eukaryotisk celle - Google Patents

Ekstracellulære vesikler fra ikke-patogene amöber, der er anvendelige som vehikel til overförsel af et molekyle af interesse til en eukaryotisk celle

Info

Publication number
DK1644045T3
DK1644045T3 DK04743927T DK04743927T DK1644045T3 DK 1644045 T3 DK1644045 T3 DK 1644045T3 DK 04743927 T DK04743927 T DK 04743927T DK 04743927 T DK04743927 T DK 04743927T DK 1644045 T3 DK1644045 T3 DK 1644045T3
Authority
DK
Denmark
Prior art keywords
interest
molecule
transferring
vehicle
pathogenic
Prior art date
Application number
DK04743927T
Other languages
Danish (da)
English (en)
Inventor
Irene Tatischeff
Annette Alfsen
Francoise Lavialle
Original Assignee
Univ Paris Curie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Paris Curie filed Critical Univ Paris Curie
Application granted granted Critical
Publication of DK1644045T3 publication Critical patent/DK1644045T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Inert Electrodes (AREA)
DK04743927T 2003-07-15 2004-07-13 Ekstracellulære vesikler fra ikke-patogene amöber, der er anvendelige som vehikel til overförsel af et molekyle af interesse til en eukaryotisk celle DK1644045T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03291752A EP1498144A1 (de) 2003-07-15 2003-07-15 Extrazelluläre Vesikel von nicht-pathogenen Amöben verwendbar für den Transfer eines Moleküles von Interesse in eine eukaryotische Zelle
PCT/IB2004/002265 WO2005004925A1 (en) 2003-07-15 2004-07-13 Extracellular vesicles from non-pathogenic amoebae useful as vehicle for transferring a molecule of interest to an eukaryotic cell

Publications (1)

Publication Number Publication Date
DK1644045T3 true DK1644045T3 (da) 2009-12-14

Family

ID=33462243

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04743927T DK1644045T3 (da) 2003-07-15 2004-07-13 Ekstracellulære vesikler fra ikke-patogene amöber, der er anvendelige som vehikel til overförsel af et molekyle af interesse til en eukaryotisk celle

Country Status (8)

Country Link
US (2) US7722855B2 (de)
EP (2) EP1498144A1 (de)
AT (1) ATE439865T1 (de)
CA (1) CA2531865C (de)
DE (1) DE602004022676D1 (de)
DK (1) DK1644045T3 (de)
ES (1) ES2331884T3 (de)
WO (1) WO2005004925A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9107949B2 (en) * 1996-11-12 2015-08-18 The University Of Akron Method for using naturally occurring gas vesicles as ultrasound contrast agent
AU2009212543B2 (en) * 2008-02-01 2015-07-09 The General Hospital Corporation Use of microvesicles in diagnosis, prognosis and treatment of medical diseases and conditions
DK2454588T3 (en) * 2009-07-16 2015-09-28 Gen Hospital Corp Nucleic acid
WO2011027956A2 (ko) * 2009-09-04 2011-03-10 주식회사이언메딕스 그람 양성 박테리아에서 유래한 세포밖 소포체 및 이를 이용한 질병 모델
WO2011027971A2 (ko) 2009-09-01 2011-03-10 주식회사이언메딕스 장내 공생 세균유래 세포밖 소포체, 및 이를 이용한 질병모델, 백신, 후보 약물 탐색 방법, 및 진단 방법
EP2475988B1 (de) 2009-09-09 2018-11-14 The General Hospital Corporation Verwendung von mikrovesikeln bei der analyse von nukleinsäureprofilen
US20130029339A1 (en) 2009-09-09 2013-01-31 The General Hospital Corporation Use of microvesicles in analyzing kras mutations
US20120315324A1 (en) * 2010-02-05 2012-12-13 University Of Louisville Research Foundation, Inc. Exosomal compositions and methods for the treatment of disease
AU2011223789A1 (en) 2010-03-01 2012-09-20 Caris Life Sciences Switzerland Holdings Gmbh Biomarkers for theranostics
KR20130043104A (ko) 2010-04-06 2013-04-29 카리스 라이프 사이언스 룩셈부르크 홀딩스 질병용 순환 생물학적 지표들
WO2012031008A2 (en) 2010-08-31 2012-03-08 The General Hospital Corporation Cancer-related biological materials in microvesicles
CA2817111C (en) 2010-11-10 2019-03-05 Exosome Diagnostics, Inc. Method for isolation of nucleic acid containing particles and extraction of nucleic acids therefrom
WO2018034457A1 (ko) * 2016-08-16 2018-02-22 주식회사 엠디헬스케어 락토바실러스 속 세균 유래 소포를 포함하는 정신질환 예방 또는 치료용 조성물
KR20180019474A (ko) 2016-08-16 2018-02-26 주식회사 엠디헬스케어 락토바실러스 플란타룸 유래 소포를 포함하는 정신질환 예방 또는 치료용 조성물
WO2018034430A1 (ko) * 2016-08-16 2018-02-22 주식회사 엠디헬스케어 락토바실러스 플란타룸 유래 소포를 포함하는 정신질환 예방 또는 치료용 조성물
MX2016014875A (es) * 2016-11-11 2018-05-10 Centro De Investig Y De Estudios Avanzados Del I P N Vesiculas extracelulares gigantes inmunogenicas de protozoos parasitos y metodos para su induccion y purificacion.
GB201702863D0 (en) * 2017-02-22 2017-04-05 Evox Therapeutics Ltd Improved loading of EVs with therapeutic proteins
CN116556020B (zh) * 2022-01-30 2026-07-24 月亮小屋(中国)有限公司 洗涤设备、用于洗涤设备的洗涤剂的投放控制方法及系统
CN115433684A (zh) * 2022-10-20 2022-12-06 云南师范大学 一种盘基网柄菌细胞同步化方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020028215A1 (en) * 1999-08-09 2002-03-07 Jagath L. Kadurugamuwa Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same

Also Published As

Publication number Publication date
EP1644045B1 (de) 2009-08-19
ATE439865T1 (de) 2009-09-15
CA2531865C (en) 2012-12-04
EP1498144A1 (de) 2005-01-19
DE602004022676D1 (de) 2009-10-01
WO2005004925A1 (en) 2005-01-20
US7790196B2 (en) 2010-09-07
US7722855B2 (en) 2010-05-25
CA2531865A1 (en) 2005-01-20
EP1644045A1 (de) 2006-04-12
ES2331884T3 (es) 2010-01-19
US20070104738A1 (en) 2007-05-10
US20100178702A1 (en) 2010-07-15

Similar Documents

Publication Publication Date Title
ATE439865T1 (de) Extrazelluläre vesikel von nicht-pathogenen amíben verwendbar für den transfer eines moleküles von interesse in eine eukaryotische zelle
WO2010042516A3 (en) System and method for route selection based on wireless coverage
CY1110491T1 (el) Διαμορφωτες του υποδοχεα γλυκοκορτικοειδους αζαδεκαλινης
DK1443312T3 (da) Fremgangsmåde til drift af en optisk sensor
GB0500655D0 (en) Improvements in or relating to network mobility
BRPI0516911A (pt) método para a preparação de um composto e composto de anilina
MY142100A (en) Gas analysis method
WO2009065508A3 (en) Water-soluble rylene dyes, methods for preparing the same and uses thereof as fluorescent labels for biomolecules
DE602006005588D1 (de) Verbesserte Diskriminatorfunktion für GPS-Codeausrichtung
DK1685247T3 (da) Vektorer til retningsbestemt kloning
ATE539320T1 (de) Routensuchverfahren und fahrzeugnavigationssystem
WO2007146905A3 (en) Navigation using tracking system multi-function devices
WO2007062148A3 (en) Chemical compounds
WO2007062151A3 (en) Chemical compounds
WO2009020430A8 (en) Method of forming a cadmium containing nanocrystal
NO20072071L (no) Flytende modulkonstruksjon
WO2007062145A3 (en) Chemical compounds
WO2005041368A9 (en) Novel molecular hydrogen gas laser
WO2007062067A3 (en) Chemical compounds
WO2007062190A3 (en) Chemical compounds
BRPI0607323B8 (pt) composições, usos de polipeptídeos e de anticorpos, bem como kits para a detecção de anticorpo que se liga especificamente a um polipeptídeo
MX2007015972A (es) Preparacion de levadura liquida estabilizada y metodo para su produccion y uso.
WO2007004092A3 (en) Novel intermediates, process for their preparation and process for the preparation of coq10 employing the said novel intermediates
EP1785482A4 (de) Verfahren zur selektion von myokardzellen unter verwendung intrazellulärer mitochondrien als anzeige
DK1907536T3 (da) Cellelinie til produktion af coronavira